I Hate You--Don't Leave Me - Jerold J. Kreisman [112]
7 Jeffrey E. Young, Janet S. Klosko, Marjorie E. Weishaar, Schema Therapy: A Practitioner’s Guide (New York: Guilford, 2003).
8 Peter Fonagy, “Thinking About Thinking: Some Clinical and Theoretical Considerations in the Treatment of a Borderline Patient,” International Journal of Psychoanalysis 72, pt. 4 (1991): 639-656.
9 Anthony Bateman and Peter Fonagy, Mentalization-Based Treatment for Borderline Personality Disorder: A Practical Guide (Oxford, UK: Oxford University Press, 2006).
10 Anthony Bateman and Peter Fonagy, “8-Year Follow-Up of Patients Treated for Borderline Personality Disorder: Mentalization-Based Treatment Versus Treatment as Usual,” American Journal of Psychiatry 165 (2008): 631-638.
11 Otto F. Kernberg, Michael A. Selzer, Harold W. Koeningsberg, et al., Psychodynamic Psychotherapy of Borderline Patients (New York: Basic Books, 1989).
12 Frank E. Yeomans, John F. Clarkin, and Otto F. Kernberg, A Primer for Transference-Focused Psychotherapy for the Borderline Patient (Lanham, MD: Jason Aronson, 2002).
13 Robert J. Gregory and Anna L. Remen, “A Manual-Based Psychodynamic Therapy for Treatment-Resistant Borderline Personality Disorder,” Psychotherapy: Theory, Research, Practice, Training 45 (2008): 15-27.
14 Eric M. Plakun, “Making the Alliance and Taking the Transference in Work with Suicidal Borderline Patients,” Journal of Psychotherapy Practice and Research 10 (2001): 269-276.
15 Allan Abbass, Albert Sheldon, John Gyra, et al., “Intensive Short-Term Dynamic Psychotherapy for DSM-IV Personality Disorders: A Randomized Controlled Trial,” Journal of Nervous and Mental Disease 196 (2008): 211-216.
16 Antonio Menchaca, Orietta Perez, and Astrid Peralta, “Intermittent-Continuous Eclectic Therapy: A Group Approach for Borderline Personality Disorder,” Journal of Psychiatric Practice 13 (2007): 281-284.
17 John F. Clarkin, Kenneth N. Levy, Mark F. Lenzenweger, et al., “Evaluating Three Treatments for Borderline Personality Disorder: A Multi-wave Study,” American Journal of Psychiatry 164 (2007): 922-928.
18 Josephine Giesen-Bloo, Richard van Dyck, Philip Spinhoven, et al., “Outpatient Psychotherapy for Borderline Personality Disorder: Randomized Trial of Schema-Focused Therapy vs. Transference-Focused Psychotherapy,” Archives of General Psychiatry 63 (2006): 649-658.
19 Antoinette D. I. van Asselt and Carmen D. Dirksen, “Outpatient Psychotherapy for Borderline Personality Disorder: Cost-Effectiveness of Schema-Focused Therapy vs. Transference-Focused Psychotherapy,” British Journal of Psychiatry 192 (2008): 450-457.
9. MEDICATIONS: THE SCIENCE AND THE PROMISE
1 Ted Reichborn-Kjennerud, “Genetics of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 421-440.
2 Randy A. Sansone and Lori A. Sansone, “The Families of Borderline Patients: The Psychological Environment Revisited,” Psychiatry 6 (2009): 19-24.
3 Bernadette Grosjean and Guochuan E. Tsai, “NMDA Neurotransmission as a Critical Mediator of Borderline Personality Disorder,” Journal of Psychiatry and Neuroscience 32 (2007): 103-115.
4 Antonia S. New, Marianne Goodman, Joseph Triebwasser, et al., “Recent Advances in the Biological Study of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 441-461.
5 Bonnie Jean Steinberg, Robert L. Trestman, and Larry J. Siever, “The Cholinergic and Noradrenergic Neurotransmitter Systems and Affective Instability in Borderline Personality Disorder,” in Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 41-62.
6 Mary C. Zanarini, Catherine R. Kimble, and Amy A. Williams, “Neurological Dysfunction in Borderline Patients and Axis II Control Subjects,” Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 159-175.
7 Jose Manuel de